Singapore markets closed

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8101-0.0359 (-4.24%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,529
15,529
13,907
4,359
0
Operating expenses
Research development
73,040
73,040
85,077
104,153
79,890
Selling general and administrative
30,616
30,616
26,410
28,527
17,944
Total operating expenses
103,656
103,656
111,487
132,680
97,834
Operating income or loss
-88,127
-88,127
-97,580
-128,321
-97,834
Total other income/expenses net
-
-
-
-
-10,548
Income before tax
-86,884
-86,884
-95,940
-128,189
-108,382
Income tax expense
795
795
106
143
161
Income from continuing operations
-87,679
-87,679
-96,046
-128,332
-108,543
Net income
-87,679
-87,679
-96,046
-128,332
-108,543
Net income available to common shareholders
-87,679
-87,679
-96,046
-128,332
-108,543
Basic EPS
-1.89
-
-2.25
-3.22
-10.87
Diluted EPS
-1.89
-
-2.25
-3.22
-10.87
Basic average shares
43,117
-
42,695
39,855
9,988
Diluted average shares
43,117
-
42,695
39,855
9,988